BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
BioPharm Executive - Golden Handshakes
Roche (RHHBY), Ascletis, Inc. to Collaborate on Hepatitis C Drugs for China 4/15/2013  More...
GlaxoSmithKline (GSK) Targets "Electroceuticals" for Potential New Therapies 4/11/2013  More...
GlaxoSmithKline (GSK) and A*STAR's Institute of Chemical Engineering and Sciences to Develop New Medicines for Emerging Markets 4/9/2013  More...
Resverlogix Corporation (RVX.TO) to Spin-Out RVX Therapeutics Inc. (RVX) 4/8/2013  More...
Roche (RHHBY) and Isis Pharmaceuticals, Inc. (ISIS) Form $392 Million Alliance for Huntington's Disease 4/8/2013  More...
AstraZeneca PLC (AZN) Shells Out $240 Million Upfront for Moderna Therapeutics mRNA Drugs 3/22/2013  More...
bluebird bio Forms Cancer Drug Partnership With Celgene Corporation (CELG) 3/21/2013  More...
Receptos Licenses AbbVie (ABBV) Antibody for Co-Development 3/14/2013  More...
Astellas Pharma Inc. (YPH.BE) and Ambit Biosciences to End Collaboration for Joint Development and Commercialization of FLT3 Kinase Inhibitors 3/13/2013  More...
Presage Biosciences Snags $13 Million From Celgene Corporation (CELG) to Pick Winning Cancer Drug Combos 3/5/2013  More...
Merck & Co., Inc. (MRK) and Samsung Corporation to Develop Biosimilar Drugs Together 2/20/2013  More...
Roche (RHHBY) and Chiasma Inc. to Ally on Drug Development for Up to $600 Million 2/20/2013  More...
RQx Pharmaceuticals, Inc. Inks $111 Million Genentech (RHHBY) Deal 2/12/2013  More...
Biogen Idec, Inc. (Massachusetts) (BIIB) to Buy Elan Corporation PLC (ELN)'s Tysabri Rights for $3.25 Billion 2/7/2013  More...
The Medicines Company (MDCO) Buys Cholesterol Drug Rights From Alnylam Pharmaceuticals (ALNY) for Up to $205 Million 2/5/2013  More...
Allergan Inc. (AGN) to Buy MAP Pharmaceuticals, Inc. (MAPP) for $958 Million 1/23/2013  More...
Life Technologies (LIFE) Gains on Buyout Speculation 1/21/2013  More...
Shire plc (SHPG) Rises on AstraZeneca PLC (AZN) Bid Talk: Traders 1/17/2013  More...
MacroGenics, Inc.'s DART Platform Grabs Potential $1 Billion Gilead Sciences, Inc. (GILD) Deal 1/8/2013  More...
Amgen (AMGN), BIND Biosciences, Inc. Ink $180 Million Tumor Treatment Deal 1/8/2013  More...
Gilead Sciences, Inc. (GILD) Bags Blood Disorder Drug With $510 Million YM BioSciences (YM.TO) Buy 12/13/2012  More...
Teva Pharmaceutical Industries Limited (TEVA) Enters $376 Million Deal for Xenon Pharmaceuticals Inc. Pain Drug 12/11/2012  More...
Amgen (AMGN) Bags Gene-Hunting Firm deCODE genetics, Inc. (DCGN) for $415 Million Cash 12/11/2012  More...
Biogen Idec, Inc. (Massachusetts) (BIIB), Isis Pharmaceuticals, Inc. (ISIS) in Drug Development Pact for Up to $630 Million 12/10/2012  More...
Sanofi (France) (SAN.PA) Deal Could Net Selecta Biosciences, Inc. $900 Million 11/29/2012  More...
Johnson & Johnson (JNJ), Eli Lilly and Company (LLY), Merck & Co., Inc. (MRK) Team Up to Form Clinical Trial Site Database 11/15/2012  More...
Forest Laboratories, Inc. (FRX) and Adamas Pharmaceuticals Form Alliance for Up to $160 Million 11/14/2012  More...
Foundation Medicine and AstraZeneca PLC (AZN) Announce Genomic Profiling Collaboration 11/12/2012  More...
Takeda Pharmaceutical Co. Ltd. (TKPYY) Shells Out $140 Million for Envoy Therapeutics 11/6/2012  More...
Amgen (AMGN) Closes Deal With Financial Firm to Open New Biotech Company Atara Biotherapeutics 10/29/2012  More...
Pfizer Inc. (PFE) Will Buy NextWave Pharmaceuticals for Up to $680 Million 10/23/2012  More...
Theravance, Inc. (THRX), Merck & Co., Inc. (MRK) Ink $153 Million Cardiovascular Pact 10/16/2012  More...
Merck & Co., Inc. (MRK), AiCuris Ink $571 Million CMV Pact 10/16/2012  More...
AstraZeneca PLC (AZN) Boosts Pipeline With $272 Million Ardelyx Inc. Drug Deal 10/9/2012  More...
Evotec AG (EVTG.F) and Bayer AG (BAY.F) Enter Into $765 Million Multi-Target Alliance to Fight Endometriosis 10/1/2012  More...
MacroGenics, Inc. Could Earn More Than $1 Billion Through New Servier Alliance 9/20/2012  More...
Baxter International, Inc. (BAX) and Onconova Therapeutics Inc. Announce European Licensing Agreement for Up to $515 Million 9/19/2012  More...
Complete Genomics, Inc. to be Bought by Chinese Firm for $117.6 Million 9/17/2012  More...
AstraZeneca PLC (AZN)'s MedImmune (AZN) Forms Chinese Joint Venture for Biologic Drug 9/11/2012  More...
Genmab A/S (GEN.CO) Inks $1.1 Billion Deal With Johnson & Johnson (JNJ) 8/31/2012  More...
Allergan Inc. (AGN), Molecular Partners AG Ink $1.5 Billion Exclusive Pact 8/21/2012  More...
AstraZeneca PLC (AZN) Buys Into Regulus Therapeutics, Inc.' MicroRNA Therapeutics for $28 Million 8/15/2012  More...
Elan Corporation PLC (ELN) Fuels Buyout Plans With $130 Million R&D Spinout, Unit Will Have Around 80 Staffers 8/14/2012  More...
S*Bio of Singapore Sells Cancer Drug Rights to MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) (MSHL) for $75 Million 8/10/2012  More...
GlaxoSmithKline (GSK) Completes $3.6 Billion Takeover of Human Genome Sciences, Inc. (HGSI) 8/6/2012  More...
Life Technologies (LIFE) Buys Navigenics for Genetic Diagnostics 7/17/2012  More...
GlaxoSmithKline (GSK) Clinches Deal to Buy Human Genome Sciences, Inc. (HGSI) for $2.8 Billion 7/16/2012  More...
Alnylam Pharmaceuticals (ALNY), Ascletis, Inc. Create Strategic Collaboration to Develop ALN-VSP 7/12/2012  More...
Verastem, Inc. (VSTM) Buys Pfizer Inc. (PFE) Cancer Drug Candidate in Deal Worth $126.5 Million 7/12/2012  More...
AstraZeneca PLC (AZN), Bristol-Myers Squibb Company (BMY) Join Forces in $7 Billion Deal for Amylin Pharmaceuticals, Inc. (AMLN) 7/3/2012  More...
AstraZeneca PLC (AZN), Rigel Pharmaceuticals, Inc. (RIGL) Strike Potential $100 Million Asthma Drug Deal 6/19/2012  More...
Roche (RHHBY)'s Genentech (RHHBY) Grabs Alzheimer's Drug Rights From AC Immune SA for $418 Million-Plus 6/19/2012  More...
GlaxoSmithKline (GSK) Rumored to be Buying $5 Billion BioMarin Pharmaceutical Inc. (BMRN) 6/13/2012  More...
GlaxoSmithKline (GSK) Pays $227 Million for Basilea Pharmaceutica (BSLN.SW) Eczema Drug 6/12/2012  More...
AstraZeneca PLC (AZN) Bids $4 Billion for Diabetes Specialist Amylin Pharmaceuticals, Inc. (AMLN) 6/5/2012  More...
Basilea Pharmaceutica (BSLN.SW) Participates in Public-private Collaboration to Tackle Antibiotic Resistance 5/25/2012  More...
Agilent Technologies Inc. (A) to Acquire Dako North America, Inc. for $2.2 Billion 5/17/2012  More...
GlaxoSmithKline (GSK)'s $2.6 Billion Bid for Human Genome Sciences, Inc. (HGSI) Goes Hostile 5/10/2012  More...
Novartis AG (NVS) Snags Fougera (AAA) for $1.5 Billion for Generic Skin Drugs 5/3/2012  More...
Axerion Therapeutics Inc., AstraZeneca PLC (AZN) Inks Pact to Combat Alzheimer's Disease 5/2/2012  More...
Amylin Pharmaceuticals, Inc. (AMLN) Explores Sale, Hires Bankers: Sources; Is AstraZeneca PLC (AZN) Interested? 4/24/2012  More...
AstraZeneca PLC (AZN) to Acquire Ardea Biosciences, Inc. for $1.26 Billion Including Lead Product Lesinurad in Phase III Development for Gout 4/23/2012  More...
Human Genome Sciences, Inc. (HGSI) Rejects GlaxoSmithKline (GSK)'s $2.6 Billion Bid, Seeks Higher Offers 4/20/2012  More...
Roche (RHHBY) Ready to Walk Away From $6.8 Billion Illumina, Inc. (ILMN) Bid 4/19/2012  More...
Amgen (AMGN) to Pay $315 Million for Privately-Held KAI Pharmaceuticals, Inc. 4/11/2012  More...
Watson Pharmaceuticals, Inc. (WPI) Close to $7 Billion Actavis Drug Deal: Sources 3/22/2012  More...
Heptares Grants Shire plc an Exclusive Worldwide $190 Million License to Develop and Commercialise Novel Drug Candidate for CNS Disorders 3/20/2012  More...
BioCon Limited (BIOCON.NS) Plunges After Pfizer Inc. (PFE) Scraps $350 Million Insulin Pact 3/14/2012  More...
EpiStem Ltd Announces a Three Year Collaboration With GlaxoSmithKline (GSK) in Fibrosis Research 3/13/2012  More...
Mersana Therapeutics, Inc. Strikes $270 Million Antibody-drug Conjugate Deal With Endo Pharmaceuticals (ENDP) 3/7/2012  More...
AngioChem, GlaxoSmithKline (GSK) Form $331 Million Pact to Discover and Develop Treatments of Lysosomal Storage Diseases 2/27/2012  More...
Enanta Pharmaceuticals, Inc. Strikes Hep C Drug Deal With Novartis AG (NVS) Worth Up to $440 Million 2/22/2012  More...
Pfizer Inc. (PFE) Eyes Tie-Ups With More Chinese Drugmakers; Will Ally With Zhejiang Hisun to Invest $545 Million in Generic Drug JV 2/21/2012  More...
Roche (RHHBY) Digs in for Long Fight as Illumina, Inc. (ILMN) Rejects $5.7 Billion Bid 2/10/2012  More...
Merck KGaA (MKGAF.PK) Signs $550 Million Cancer Pact With Threshold Pharmaceuticals, Inc. (THLD) 2/3/2012  More...
Genentech (RHHBY) Pours $95 Million into Constellation Pharmaceuticals Epigenetic Drug Platform, Deal Includes M&A Terms 1/17/2012  More...
Roche (RHHBY) Signs $646 Million Pain Pact With Xenon Pharmaceuticals Inc. 1/10/2012  More...
Bristol-Myers Squibb Company (BMY) to Acquire Inhibitex, Inc. (INHX) for $2.5 Billion 1/9/2012  More...
FORMA Therapeutics, Inc. Cuts $815 Million Deal With Boehringer Ingelheim Corporation to Discover Cancer Drugs 1/5/2012  More...
Alexion Pharmaceuticals Inc. (ALXN) to Pay $1 Billion for Enobia Pharma 12/29/2011  More...
Pharmacyclics, Inc. (PCYC) Could Get $975 Million in Johnson & Johnson (JNJ) License Deal 12/9/2011  More...
AstraZeneca PLC (AZN) Digs Deeper in China With Generics Buy 12/8/2011  More...
Biogen Idec, Inc. (Massachusetts) (BIIB) Teams With Samsung Corporation on $300 Million Biosimilar Venture 12/6/2011  More...
MacroGenics, Inc. Inks Pharma Deal With Servier Worth Up to $450 Million 12/1/2011  More...
Roche (RHHBY) and PTC Therapeutics, Inc. Sign $490 Million Deal for Genetic Disease Program 11/29/2011  More...
Gilead Sciences, Inc. (GILD) to Acquire Pharmasset, Inc. (VRUS) for $11 Billion 11/22/2011  More...
AMAG Pharmaceuticals, Inc. (AMAG) Hires Jefferies and Co. to Explore Sale 11/17/2011  More...
Gilead Sciences, Inc. (GILD) and Johnson & Johnson (JNJ)'s Tibotec Pharmaceuticals Ltd to Create Combination HIV Therapy 11/16/2011  More...
Lundbeck Inc. Pays Otsuka Pharmaceutical Co., Ltd. $200 Million Upfront in CNS Drug Deal, Complete Deal is Worth $1.8 Billion if Milestones are Met 11/14/2011  More...
Amylin Pharmaceuticals, Inc. (AMLN), Eli Lilly and Company (LLY) End Bydureon Pact; Amylin to Make $1.45 Billion in Payments 11/8/2011  More...
Abbott Laboratories (ABT) to Split Into 2 Companies 10/21/2011  More...
GlaxoSmithKline (GSK) May Make $4.8 Billion Bid for Human Genome Sciences, Inc. (HGSI): Source 10/19/2011  More...
Roche (RHHBY) Buys Anadys Pharmaceuticals, Inc. (ANDS) for $230 Million to Boost Hepatitis Ops 10/17/2011  More...
GlycoMimetics, Inc. Inks Licensing Deal Worth Up to $340 Million with Pfizer Inc. (PFE) 10/11/2011  More...
PPD, Inc. (PPDI) to be Acquired by The Carlyle Group and Hellman & Friedman for $3.9 Billion 10/4/2011  More...
Bristol-Myers Squibb Company (BMY) and Ambrx, Inc. Announce $24 Million Collaboration for Novel Biologics Programs in Diabetes and Heart Failure 9/22/2011  More...
Roche (RHHBY), Evotec AG (EVTG.F) Sign Alzheimer's Pact Worth Up to $830 Million 9/7/2011  More...
f-Star, Merck Serono Sign $708 Million Deal for Antibody-Derived Therapeutics 9/7/2011  More...
Astellas Pharma Inc. (YPH.BE), Evec Team Up for Antibody Pact Worth Up to $176.8 Million 9/6/2011  More...
Sanofi (France) (SASY.PA) Strikes Deal With Pfizer Inc. (PFE) to Make Generic Lipitor 9/1/2011  More...
Carlyle Group in Talks to Buy PPD, Inc. (PPDI) for as Much as $4.3 Billion 8/17/2011  More...
QIAGEN N.V. (QGEN) and Pfizer Inc. (PFE) Partner to Develop Companion Diagnostic for Novel Compound in Global Clinical Trials for Lung Cancer 8/16/2011  More...
4-Antibody AG Forms Collaboration with Human Genome Sciences, Inc. (HGSI) 8/16/2011  More...
AMAG Pharmaceuticals, Inc. (AMAG) Investor MSMB Makes $378 Million Takeover Bid for Firm to Stop Merger With Allos Therapeutics, Inc. (ALTH) 8/3/2011  More...
Bristol-Myers Squibb Company (BMY) to Pay Up to $475 Million for Amira Pharmaceuticals, Inc., Scoops Up Lung Drug 7/22/2011  More...
Novartis AG Ends Pursuit of Gen-Probe Incorporated (GPRO) 7/22/2011  More...
AMAG Pharmaceuticals, Inc. (AMAG), Allos Therapeutics, Inc. (ALTH) to Merge in $686 Million Deal 7/20/2011  More...
Micromet Inks Cancer Drug Deal With Amgen (AMGN) Worth Up to $1.01 Billion 7/12/2011  More...
Bristol-Myers Squibb Company (BMY), Innate Pharma (IPH.PA ) Announce $465 Million Deal for an Investigational Immuno-Oncology Biologic; Innate to Receive $35 Million Upfront, Shares Soar 7/7/2011  More...
Vertex Pharmaceuticals (MA) (VRTX) in Licensing Pact Potentially Worth $1.5 Billion With Alios BioPharma to Expand Hepatitis Pipeline 6/13/2011  More...
Merck & Co., Inc. (MRK) Buys Hanwha Drug-Marketing Rights for $720 Million 6/13/2011  More...
Merck & Co., Inc. (MRK), Roche (RHHBY) Pair Up on Tests for Cancer Treatments 6/7/2011  More...
Clovis Oncology (CLVS) Receives License for Worldwide Development and Commercialization Rights to Pfizer Inc. (PFE)'s Oral and IV PARP Inhibitor PF-01367338 6/3/2011  More...
AVEO Pharmaceuticals, Inc. (AVEO) Enters into Worldwide License Agreement with Centocor Ortho Biotech Products, L.P.; AVEO Receives $15 Million; Eligible for up to $540 Million 5/31/2011  More...
Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Nails Nycomed Buyout for $13.7 Billion, Skin Unit to Spin Off 5/19/2011  More...
Allos Therapeutics, Inc. (ALTH) and Mundipharma AG Announce Strategic Collaboration for FOLOTYN; Allos to Receive $50 Million Upfront; Potentially up to $310.5 Million 5/11/2011  More...
Alkermes (ALKS), Elan Drug Technologies in $960 Million Merger 5/9/2011  More...
Teva Pharmaceutical Industries Limited (TEVA) to Buy Japanese Generic Drugmaker, Taiyo Pharmaceuticals Industry Co. Ltd. for $490 Million 5/3/2011  More...
Teva Pharmaceutical Industries Limited (TEVA) to Buy Cephalon, Inc. (CEPH) for Over $6 Billion, Tops Valeant Pharmaceuticals International (VRX) 5/2/2011  More...
Sanofi-Aventis (Canada) Enters into Collaboration Agreement with Stanford University Bio-X to Focus on Early-Stage Scientific Research 4/18/2011  More...
Exelixis, Inc. (EXEL) Said to Hire Goldman, Sachs & Co. to Field Possible Takeover Approaches; Shares Rise on Speculation 4/12/2011  More...
Zacharon Pharmaceuticals, Inc. Announces Potential $200 Million Collaboration With Pfizer Inc. (PFE) to Develop Drugs for Multiple Rare Disorders 4/7/2011  More...
Cephalon, Inc. (CEPH) Spurns Valeant Pharmaceuticals International (VRX)'s $5.7 Billion Hostile Bid as Too Low 4/6/2011  More...
Merck & Co., Inc. (MRK) to Acquire Inspiration Biopharmaceuticals for $430 Million 4/6/2011  More...
Seattle Genetics, Inc. (SGEN) Announces Antibody-Drug Conjugate Collaboration with Abbott Laboratories (ABT); Seattle Genetics Gets $8 Million Upfront; Eligible for as much as $200 Million 3/22/2011  More...
Cephalon, Inc. (CEPH) to Acquire Gemin X Pharmaceuticals, Inc. for $225 Million; up to $300 Million in Milestones 3/22/2011  More...
FivePrime Therapeutics, Inc. Nabs $495M Deal With Human Genome Sciences, Inc. (HGSI) to Develop Cancer Drug 3/17/2011  More...
Research Unit Going to China, Pfizer Inc. (PFE) Says; Company Plans Gradual Move of Antibacterials Operations to Shanghai 3/16/2011  More...
Daiichi Sankyo, Inc. (D4S.F) to Acquire Plexxikon Inc. for $805 Million Upfront, Approval of PLX4032 Could Bring in an Additional $130 Million 3/1/2011  More...
Sanofi-Aventis (France) (SASY.PA) to Buy Genzyme Corporation (GENZ) for Over $20 Billion; Most Genzyme Jobs Safe 2/17/2011  More...
Astellas Pharma Inc. (YPH.BE) to Pay AVEO Pharmaceuticals, Inc. (AVEO) as Much as $1.3 Billion for Kidney Cancer Medicine; AVEO to Get $125M Upfront 2/17/2011  More...
ADVENTRX Pharmaceuticals Inc. (ANX) Signs Definitive Agreement to Acquire SynthRx, Inc. 2/14/2011  More...
Danaher to Buy Beckman Coulter, Inc. (BEC) for $6.8 Billion 2/9/2011  More...
Optimer Pharmaceuticals, Inc. (OPTR), Astellas Pharma Inc. (YPH.BE) Sign Collaboration For Antibiotic Fidaxomicin; Optimer Eligible to Receive Milestone Payments of up to $224 Million Including $68 Million Upfront Cash Payment 2/7/2011  More...
Genoptix, Inc. Announces Agreement to be Acquired by Novartis Corporation (NVS) for $470 Million 1/25/2011  More...
Theraclone Sciences, Inc. and Pfizer Inc. (PFE) Enter into Infectious Disease and Cancer Antibody Discovery Collaboration; Pfizer to Pay up to $632M 1/19/2011  More...
Eli Lilly and Company (LLY) and Boehringer Ingelheim Corporation Announce Strategic Alliance to Bring New Diabetes Treatments to Patients Worldwide; Boehringer Ingelheim to Get 300M Euro; up to a Total of 625M Euro 1/12/2011  More...
Bristol-Myers Squibb Company (BMY) and Pharmasset, Inc. (VRUS) Enter into a Clinical Collaboration Agreement for Proof of Concept Combination Study in Patients Chronically Infected with Hepatitis C 1/10/2011  More...
Seattle Genetics, Inc. (SGEN), Pfizer Inc. (PFE) in $208 Million Antibody Tech Deal 1/7/2011  More...
As Deadline Nears, Suitor Genzyme Corporation (GENZ) May Have to Revise Bid For Sanofi-Aventis K.K. 12/10/2010  More...
Johnson & Johnson (JNJ) Launches $2.3 Billion Bid for Crucell N.V. (CRXL) 12/8/2010  More...
Dicerna Pharmaceuticals Expands Pact Kyowa Hakko Kirin; Original Agreement Worth $1.4 Billion Potentially 12/7/2010  More...
GE Healthcare and Johnson & Johnson (JNJ)'s Janssen Pharmaceutica N.V. Deal Pairs Two Alzheimer's Powerhouses 12/3/2010  More...
Merck & Co., Inc. (MRK) to Buy SmartCells, Inc. in Deal Worth Possibly $500 Million 12/2/2010  More...
GlaxoSmithKline (GSK) to Buy $129.4M in Theravance, Inc. (THRX) Stock 11/30/2010  More...
Amgen (AMGN) Said to Consider Actelion Ltd. (ALIOF.PK) Takeover Bid to Gain Rare Disease Drugs 11/17/2010  More...
Genzyme Corporation (GENZ) in Talks to Sell Itself to Takeda Pharmaceutical Co. Ltd. (TKDG.DE) for $18.5 Billion 11/15/2010  More...
Clavis Pharma ASA and Clovis Oncology Sign New $205 Million Deal For Pancreatic Cancer Drug in Asia And Rest of World 11/11/2010  More...
Eli Lilly and Company (LLY) to Acquire Avid Radiopharmaceuticals, Inc. in $800 Million Deal 11/9/2010  More...
McKesson Corporation Pays $2 Billion To Buy US Oncology, Inc. 11/2/2010  More...
BioCon Limited, Pfizer Inc. (PFE) In Potential $350 Million Insulin Licensing Deal 10/19/2010  More...
UCB SA And Synosia Therapeutics Sign Parkinson's Disease Alliance Worth $745 Million Potentially 10/12/2010  More...
ImmunoGen, Inc. (IMGN) Signs Cancer Treatment Deal With Novartis AG; Immunogen to Receive $45 Million Upfront With Potential for $200 Million 10/12/2010  More...
Pfizer Inc. (PFE) To Buy King Pharmaceuticals®, Inc. For $3.6 Billion Cash 10/12/2010  More...
Exelixis, Inc. (EXEL) Licenses Two Drug Programs To Bristol-Myers Squibb Company (BMY); Exelixis Nabs $60M Upfront, Potentially $505M More 10/11/2010  More...
Johnson & Johnson (JNJ) Aims to Buy Vaccine Maker Crucell N.V. (CRXL) for 1.75 Billion Euros ($2.3 Billion) 9/17/2010  More...
Genzyme Corporation (GENZ) to Sell Genetics Unit to Laboratory Corporation of America Holdings (LabCorp) (LH) for $925 Million; Genzyme Cutting 1,000 Jobs Over Next 15 Months 9/14/2010  More...
Roche (RHHBY), reMYND Sign $637M Early-Stage Parkinson, Alzheimer Deal 9/8/2010  More...
Bristol-Myers Squibb Company (BMY) to Acquire ZymoGenetics, Inc. (ZGEN) For $885 Million 9/8/2010  More...
Onyx Pharmaceuticals, Inc. (ONXX) Licenses to Ono Pharmaceutical Company, Ltd. Japanese Rights to Cancer Drug For More Than $300 Million 9/8/2010  More...
Takeda Pharmaceutical Co. Ltd. (TKDG.DE) And Orexigen Therapeutics, Inc. (OREX) Sign $1 Billion Obesity Pact 9/3/2010  More...
Quark Pharmaceuticals Inc., Novartis Corporation (NVS) Sign $670-Mln Drug Deal 8/19/2010  More...
Any Sanofi-Aventis (France) (SASY.PA) Deal For Genzyme Corporation (GENZ) May Take Time, At Limited Price 8/19/2010  More...
Life Technologies (LIFE) To Buy DNA Sequencing Company, Ion Torrent Systems, Inc. For $375 Mln 8/18/2010  More...
Alectos Therapeutics Announces Collaboration With Merck & Co., Inc. (MRK) to Develop Drugs for Alzheimer's Disease; Alectos Therapeutics Could Receive $289 Million 8/11/2010  More...
GlaxoSmithKline (GSK) and Amplimmune Form Global Strategic Collaboration; GSK to Pay Amplimmune $23 Million Upfront; Deal Worth up to $485 Million 8/4/2010  More...
Conatus Pharmaceuticals Inc. Buys Back Idun Pharmaceuticals, Inc. From Pfizer Inc. (PFE) 8/2/2010  More...
Sanofi-Aventis (France) (SASY.PA), GlaxoSmithKline (GSK) Eyes Troubled Genzyme Corporation (GENZ); Genzyme Rebuffs Sanofi Bid 7/28/2010  More...
Mylan Inc. (MYL) To Buy Bioniche Pharma USA LLC For $550 Mln 7/15/2010  More...
Genentech (RHHBY) Nabs License to MRC Technology's CNS Disease Candidates 7/12/2010  More...
Infinity Pharmaceuticals Inc. (INFI) and Intellikine, Inc. Enter Agreement to Develop Oral Therapies Targeting PI3 Kinase Delta, Gamma; Intellikine To Receive $13.5 Million Initially In Deal Valued Up to $488 Million 7/8/2010  More...
Arena Pharmaceuticals, Inc. (ARNA) Picks Japan's Eisai Inc. (ESALF.PK) To Market Obesity Drug Lorcaserin In Deal Worth $1.3 Billion Potentially 7/1/2010  More...
Celgene (CELG) to Buy Abraxis BioScience, Inc. for $2.9 Billion 6/30/2010  More...
Gilead Sciences, Inc. (GILD) to Acquire CGI Pharmaceuticals, Inc. for Up to $120 Million 6/25/2010  More...
Sanofi-Aventis (France) (SASY.PA) and Regulus Therapeutics, Inc. Form Major Strategic Alliance, Largest microRNA Therapeutics Alliance to Date, Valued at Potentially Over $750 Million 6/22/2010  More...
Biovail Corporation (BVF), Valeant Pharmaceuticals International (VRX) in $3.2B Reverse Merger; Valeant Shareholders to Get $16.77/Share Special Dividend 6/21/2010  More...
Bayer Schering Pharma and OncoMed Pharmaceuticals, Inc. Enter Strategic Alliance to Develop Anti-Cancer Stem Cell Therapeutics; OncoMed to Get $40 Million Upfront; up to $387.5 Million 6/17/2010  More...
Abbott Laboratories (ABT), Neurocrine Biosciences, Inc. (NBIX) in Pact for Endometriosis Drug, Elagolix; Neurocrine to Get up to $575 Million 6/16/2010  More...
Forest Laboratories, Inc. (FRX) and TransTech Pharma, Inc. Enter Into License Agreement for the Development and Commercialization of Glucokinase Activators; Deal Valued at Up to $1.105 Billion 6/8/2010  More...
Grifols in Friendly $3.4 Billion Takeover of Talecris Biotherapeutics (TLCR) 6/7/2010  More...
Abbott Laboratories (ABT) Buys Piramal Healthcare Limited Biz for $3.72B 5/21/2010  More...
Astellas Pharma Inc. Buys OSI Pharmaceuticals, Inc. (OSIP) for $4 Billion in Cancer Push 5/17/2010  More...
Pfizer Inc. (PFE) Enters Into Agreement With ErgoNex Pharma GmbH to Acquire Investigational Treatment for Pulmonary Arterial Hypertension 5/12/2010  More...
Evotec AG (EVTG.F) Enters Into Integrated Drug Discovery Alliance With Genentech (RHHBY) 5/10/2010  More...
Genzyme Corporation (GENZ) OKs $2B Buyback, Company to Shed Three Extraneous Units 5/7/2010  More...
Ariad Pharmaceuticals, Inc. (ARIA) Says Partner Merck & Co., Inc. (MRK) to Acquire Cancer Treatment; Ariad to Receive $50 Million Upfront Payment and up to $514 Million 5/5/2010  More...
Glenmark Pharmaceuticals, Sanofi (France) (SAN.PA) in $345 Million Drug-Licensing Pact 5/3/2010  More...
Array BioPharma, Inc. (ARRY) Inks $467 Million Deal with Novartis AG 4/20/2010  More...
Astellas Pharma Inc.: Won't Raise OSI Pharmaceuticals, Inc. (OSIP) Bid on FDA Move Alone 4/19/2010  More...
Hospira, Inc. (HSP) and Javelin Pharmaceuticals (JAV) Enter Into Definitive Merger Agreement for Hospira to Acquire Javelin for Approximately $145 Million 4/19/2010  More...
Elan Corporation PLC (ELN) Mulls Spinning Off Drug Delivery Unit to Create Two Publicly Listed Companies 4/19/2010  More...
Celgene (CELG) and Agios Pharmaceuticals Announce Global Strategic Collaboration to Advance Unique Science of Cancer Metabolism; Agios Will Receive $130 Million Upfront 4/15/2010  More...
GlaxoSmithKline (GSK), Isis Pharmaceuticals, Inc. (ISIS) in Drug Development Deal of up to $1.5 Billion 4/1/2010  More...
AMAG Pharmaceuticals, Inc. (AMAG) Enters into Anemia Drug Licensing Deal with Takeda Pharmaceutical Co. Ltd. (TKDG.DE); AMAG to Get $60 Million Upfront, Eligible for $220 Million in Milestone Payments 4/1/2010  More...
Biogen Idec, Inc. (Massachusetts) (BIIB) Reaches Deal with Icahn; Avoids Proxy Fight 3/22/2010  More...
GlaxoSmithKline (GSK) Up as Novartis Corporation (NVS) Drops Generic Advair in U.S.; Novartis Hands Back U.S. Rights to VR315 to Vectura Limited 3/18/2010  More...
Teva Pharmaceutical Industries Limited (TEVA) to Acquire Ratiopharm for Nearly $5 Billion 3/18/2010  More...
OSI Pharmaceuticals, Inc. (OSIP) Board Rejects Astellas Pharma Inc. (JOBS) $3.5 Billion Bid 3/15/2010  More...
Novartis Corporation (NVS) Takes Option on TRANSGENE (TRGNY) Cancer Vaccine; Transgene Gets $10 Million, Milestones Could Reach $950 Million 3/10/2010  More...
Abbott Laboratories (ABT) (JOBS) to Buy Facet Biotech (JOBS) for $722 Million 3/10/2010  More...